与H因子相关的1和肝素硫酸盐结构有助于补充C3球细胞病变中的失调
Amanda K Slagle1,2, Nicolo Ghiringhelli Borsa1, Kai Wang3
1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa, IA, United States.
在C3结晶体病 (C3G) 中的补充失调涉及H因子 (FH) 和与H因子相关的蛋白1 (FHR-1). 增加的FHR-1与FH比率与功能下降有关,增强补充活性,并可能导致病的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 补充系统生物学 补充系统生物学
背景情况:
- C3球囊病变 (C3G) 发病过程涉及补体替代途径的失调.
- 通常情况下,H因子 (FH) 抑制补充活性,而与H因子相关的蛋白1 (FHR-1) 则被认为可以促进补充活性.
研究的目的:
- 在C3G.中调查FH和FHR-1之间的平衡.
- 评估FHR-1在C3G致病性中的作用及其对补充活性的功能影响.
主要方法:
- 多重联结依赖的探头放大,以检测CFHR3-CFHR1副本数变体.
- 与酶相关的免疫吸收试验测量循环中的FH和FHR-1蛋白水平.
- 在体外C3b沉积测试以评估FHR-1功能.
主要成果:
- 增加的CFHR3-CFHR1拷贝数与C3G风险有关.
- 在C3G患者中观察到的FHR-1:FH蛋白比率升高与功能下降相关,不特定于C3G.
- FHR-1 与 FH 竞争,增加 C3b 沉积,这种效应由肝素硫酸盐裂变放大.
结论:
- 功能下降会改变FHR-1:FH比率和肝素硫酸盐结构,增加补充活性.
- 这种补充激活可能会导致慢性炎症和慢性病中的损伤进展.
更多相关视频
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
10:05A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
Published on: March 18, 2021
相关概念视频
Complement System
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Proteoglycans
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
